Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Werner

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Environment International|August 29, 2025
A Scheme for Safety Testing and Assessment of Biochemicals under the EU Plant Protection Products Regulation (BiochemPPP-STAS)Rosa Criollo, Marie-Noêlle Douaiher, Orçun Gürkan, et al.
Scientific Reports|October 22, 2021
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancementJurij Rosen, Gabriele Stoffels, Philipp Lohmann, et al.
Neuro-Oncology Advances|December 31, 2025
Assessment of <sup>18</sup>F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteriaGarry Ceccon, Michael Wollring, Isabelle Stetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
MRI and <sup>18</sup>F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness AnalysisJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.
Hemasphere|June 17, 2026
Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology-oncology co-managementJan-Michael Werner, Philipp Gödel, Norbert Galldiks, et al.
Neuro-Oncology|October 10, 2022
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PETMichael M Wollring, Jan-Michael Werner, Elena K Bauer, et al.
Neuro-Oncology|July 6, 2024
PET imaging of gliomas: Status quo and quo vadis?Norbert Galldiks, Philipp Lohmann, Michel Friedrich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Assessment of Response to Regorafenib in Patients with Glioma Relapse Using <sup>18</sup>F-FET PET and MRIJan-Michael Werner, Philipp Lohmann, Christoph Kabbasch, et al.
Neuro-Oncology|August 23, 2019
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogressionNorbert Galldiks, Martin Kocher, Garry Ceccon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based reviewDenise M Oliansky, Leo I Gordon, Jerry King, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Environment International|August 29, 2025
A Scheme for Safety Testing and Assessment of Biochemicals under the EU Plant Protection Products Regulation (BiochemPPP-STAS)Rosa Criollo, Marie-Noêlle Douaiher, Orçun Gürkan, et al.
Scientific Reports|October 22, 2021
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancementJurij Rosen, Gabriele Stoffels, Philipp Lohmann, et al.
Neuro-Oncology Advances|December 31, 2025
Assessment of <sup>18</sup>F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteriaGarry Ceccon, Michael Wollring, Isabelle Stetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
MRI and <sup>18</sup>F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness AnalysisJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.
Hemasphere|June 17, 2026
Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology-oncology co-managementJan-Michael Werner, Philipp Gödel, Norbert Galldiks, et al.
Neuro-Oncology|October 10, 2022
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PETMichael M Wollring, Jan-Michael Werner, Elena K Bauer, et al.
Neuro-Oncology|July 6, 2024
PET imaging of gliomas: Status quo and quo vadis?Norbert Galldiks, Philipp Lohmann, Michel Friedrich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Assessment of Response to Regorafenib in Patients with Glioma Relapse Using <sup>18</sup>F-FET PET and MRIJan-Michael Werner, Philipp Lohmann, Christoph Kabbasch, et al.
Neuro-Oncology|August 23, 2019
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogressionNorbert Galldiks, Martin Kocher, Garry Ceccon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based reviewDenise M Oliansky, Leo I Gordon, Jerry King, et al.
Pageof 16